Skip to main content
ASKA Pharmaceutical Holdings Co., Ltd.ASKA Pharmaceutical Holdings Co., Ltd.
  • Contact Us
  • Accessibility
LANGUAGE
JP
EN
  • HOME
    • About ASKA Pharmaceutical Holdings
      • Top Message
      • Corporate Philosophy
      • Company Overview
      • Code of Corporate Conduct
      • Leadership
      • Company Information
      • Group Companies
      • Business Activities
      • Corporate Message
      • Digital Transformation
      • ASKA Pharmaceutical Holdings in Numbers
    • For Our Shareholders and Investors
      • Top Message
      • IR News
      • IR Library
      • IR Calendar
      • Management Strategies and Policies
      • Governance
      • Financial Highlights
      • ASKA Pharmaceutical Holdings at a glance
      • IR Related Information
      • Stock and Shareholder Information
    • Sustainability
      • Our Sustainability
      • Environmental
      • Social
      • Governance (Related Link)
      • ESG Chart and ESG Data Book
      • External Evaluation
      • Initiatives and Member Organizations
      • Third-party Opinion
      • Sustainability News
      • Various Contrasting Tables
      • Policies (Related Link)
      • Integrated Report (Related Link)
    • Press Releases
    • Contact Us
    • Privacy Policy
    • Basic Policy on the Proper Handling of Specific Personal Information, etc.
    • Terms of Use
    • Web Accessibility Policy
    • SNS Community Guidelines
      • Official website and SNS
    • Sitemap
    • Search Results
    • Important Notice
About ASKA Pharmaceutical Holdings
  • Company Overview
  • Group Companies
  • Top Message
  • Corporate Philosophy
  • Code of Corporate Conduct
  • Leadership
  • Company Information
  • Business Activities
  • Corporate Message
  • Digital Transformation
  • ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
  • Top Message
  • Management Strategies and Policies
  • IR News
  • IR Library
  • IR Calendar
  • Governance
  • Financial Highlights
  • ASKA Pharmaceutical Holdings at a glance
  • IR Related Information
  • Stock & Shareholder Information
Sustainability
  • Integrated Report (Related links)
  • Our Basic Policy for Sustainability
  • Various Contrasting Tables
  • Our Sustainability
    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Capital and Strengths
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
    • Disclosures based on TNFD recommendations
  • Environmental Governance (Related links) External Evaluation Third-party Opinion Various Contrasting Tables Integrated Report (Related links)
  • Social ESG Chart and ESG Data Book Initiatives and Member Organizations Sustainability News Policies (Related links)
[ Important Notice ] Alert on False Emails Impersonating the Representative Director of ASKA Pharmaceutical Co., Ltd.
[ Important Notice ]
Alert on False Emails Impersonating the Representative Director of ASKA Pharmaceutical Co., Ltd.

NEWS RELEASES

RSS
  • July 30 2026
    Added "Build Muscle for the Future: Exercises for Those Concerned About Declining Physical Strength" to Mint⁺ Exercise.(Japanese version only)
  • July 14 2026
    ESG Data Book 2026 is now available
  • July 03 2026
    The "Mid-Term Management Plan 2028" page is now available.
  • June 29 2026
    ASKA Pharmaceutical Announces FY2026 Call for Drug Discovery Research Proposals[PDF]242.33 KB
  • June 19 2026
    Notice Regarding the Release of Our Corporate Profile Video
NEWS RELEASES

IR NEWS

RSS
IR NEWS

IR E-mail Newsletter Service

Receive our latest IR information by e-mail.

Subscribe to the Service

ASKA VISION 2035

Toward a Specialty Healthcare Company Based in Japan,
Pioneering the Future Globally

ASKA Pharmaceutical Holdings Long-Term Vision

ASKA Pharmaceutical Holdings Group

ASKA Pharmaceutical Holdings Group

  • ASKA Pharmaceutical Co., Ltd.
  • ASKA Animal Health Co., Ltd.
    (Japanese version only)
  • ASKA Pharma Medical Co., Ltd.
    (Japanese version only)
  • Ha Tay Pharmaceutical Joint Stock Company

For Our Shareholders and Investors

  • Top Message
  • Financial Highlights
  • Integrated Report
  • Medium-Term Management Plan
  • ASKA Pharmaceutical Holdings at a glance
  • IR Library
  • IR Calendar
  • Management Strategies and Policies
  • Governance
  • IR Related Information
  • Stock & Shareholder Information

About ASKA Pharmaceutical Holdings

  • Company Profile

    • Top Message
    • Corporate Philosophy
    • Company Overview
    • Code of Corporate Conduct
    • Leadership
    • Company Information
    • Group Companies
    • Business Activities
    • Corporate Message
    • Digital Transformation
    • ASKA Pharmaceutical Holdings in Numbers
  • Sustainability

    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Capital and Strengths
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
    • Disclosures based on TNFD recommendations
    • Environmental
    • Social
    • Corporate Governance (Related links)
    • ESG Chart and ESG Data Book
    • External Evaluation
    • Initiatives and Member Organizations
    • Third-party Opinion
    • Sustainability News
    • Various Contrasting Tables
    • Policies (Related links)
    • Integrated Report (Related links)
Ha Tay Pharmaceutical Joint Stock Company
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Web Accessibility Policy
  • SNS Community Guidelines
  • Sitemap
Copyright © ASKA Pharmaceutical Holdings Co., Ltd. All Rights Reserved.
TOP
5GmrFB2020XnTzWpt60iiVEb4VkBv7mhKDwl6D1aCkc=.html